Market

The company reported a consolidated revenue of ₹4,031 crore for the first quarter of fiscal year 2027, reflecting a significant 12.89% annual growth. This financial achievement underscores the robust performance of its domestic portfolio, which continues to outpace the general Indian pharmaceutical

Biopharmaceutical companies in France are utilizing disposable systems to remain competitive by shortening the downtime required between different product batches. This shift represents a fundamental realignment of industrial priorities, moving away from the rigid, permanent infrastructure of the

A record 383 vials of LYMPHIR were ordered in July, establishing a new performance benchmark for the company’s expanded 29-member nationwide sales infrastructure. This milestone represents a significant pivot for Citius Pharmaceuticals as it transitions from a clinical-stage entity into a

Securing an MSCI AAA ESG rating and an EcoVadis Platinum Medal places WuXi Biologics in the top 1% of companies evaluated for environmental and social governance. This landmark achievement underscores the organization's role as a dominant force in the global healthcare market, particularly as it

Hims & Hers is currently navigating a complex period of transition as it trades its historical high-margin profile for a dominant position in the weight-loss sector. Operating at a volatile crossroads where rapid corporate expansion meets intense federal oversight, the leading telehealth platform

Although 75 percent of the public believes weight-loss drugs are used for cosmetic reasons, 66 percent still find their use to be socially acceptable in modern society. This fundamental shift in perception coincides with the rise of glucagon-like peptide-1 receptor agonists, which have